NO20031071L - Fremgangsmåte for å inhibere nedgang i transdermal medikamentgjennomströmming ved inhibisjon ved lukking av reaksjonsveien - Google Patents

Fremgangsmåte for å inhibere nedgang i transdermal medikamentgjennomströmming ved inhibisjon ved lukking av reaksjonsveien

Info

Publication number
NO20031071L
NO20031071L NO20031071A NO20031071A NO20031071L NO 20031071 L NO20031071 L NO 20031071L NO 20031071 A NO20031071 A NO 20031071A NO 20031071 A NO20031071 A NO 20031071A NO 20031071 L NO20031071 L NO 20031071L
Authority
NO
Norway
Prior art keywords
agent
inhibiting
inhibition
closing
decrease
Prior art date
Application number
NO20031071A
Other languages
English (en)
Other versions
NO20031071D0 (no
Inventor
Weiqi Lin
Michel J N Cormier
Peter E Daddona
Juanita A Johnson
James A Matriano
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO20031071D0 publication Critical patent/NO20031071D0/no
Publication of NO20031071L publication Critical patent/NO20031071L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Surgical Instruments (AREA)

Abstract

Oppfinnelsen angår en fremgangsmåte for å inhibere nedgang i den transdermale gjennomstrømning av et middel som transdermalt avleveres eller det tas prøver av over en lengre tidsperiode, der avleveringen eller innsamlingen involverer ødeleggelse av minst stratum corneumlaget av huden for å danne overføringsveier gjennom hvilket middelet kan passere. Det ønskete resultat oppnås ved samtidig tilførsel eller samtidig innsamling av middelet med en mengde av minst ett ikke-sårhelende middel der mengden av det ikke-sårhelende middel er effektivt til å inhibere nedgangen i middelets transdermale gjennomstrømning, sammenliknet med når avleveringen eller prøvetakingen av middelet utføres under hovedsakelig identiske betingelser med unntak av fravær av det ikke-sårhelende middel.
NO20031071A 2000-09-08 2003-03-07 Fremgangsmåte for å inhibere nedgang i transdermal medikamentgjennomströmming ved inhibisjon ved lukking av reaksjonsveien NO20031071L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23116000P 2000-09-08 2000-09-08
PCT/US2001/027551 WO2002019985A2 (en) 2000-09-08 2001-09-06 Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure

Publications (2)

Publication Number Publication Date
NO20031071D0 NO20031071D0 (no) 2003-03-07
NO20031071L true NO20031071L (no) 2003-05-06

Family

ID=22867983

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031071A NO20031071L (no) 2000-09-08 2003-03-07 Fremgangsmåte for å inhibere nedgang i transdermal medikamentgjennomströmming ved inhibisjon ved lukking av reaksjonsveien

Country Status (24)

Country Link
US (1) US7438926B2 (no)
EP (1) EP1335711B1 (no)
JP (2) JP5507030B2 (no)
KR (1) KR100764699B1 (no)
CN (1) CN100421653C (no)
AT (1) ATE367805T1 (no)
AU (2) AU2001288774B2 (no)
BR (1) BR0113749A (no)
CA (1) CA2422200A1 (no)
CZ (1) CZ2003687A3 (no)
DE (1) DE60129585T2 (no)
DK (1) DK1335711T3 (no)
EE (1) EE200300095A (no)
ES (1) ES2290166T3 (no)
IL (1) IL154811A0 (no)
MA (1) MA25958A1 (no)
MX (1) MXPA03002122A (no)
NO (1) NO20031071L (no)
NZ (1) NZ524646A (no)
PL (1) PL365603A1 (no)
PT (1) PT1335711E (no)
RU (1) RU2272618C2 (no)
WO (1) WO2002019985A2 (no)
ZA (1) ZA200302700B (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE367805T1 (de) * 2000-09-08 2007-08-15 Alza Corp Transdermale vorrichtung
ATE428466T1 (de) * 2000-10-26 2009-05-15 Alza Corp Transdermales arzneistoffverabreichungssytem mit beschichteten mikrovorsprüngen
US6908453B2 (en) * 2002-01-15 2005-06-21 3M Innovative Properties Company Microneedle devices and methods of manufacture
AU2004255218A1 (en) * 2003-06-30 2005-01-20 Alza Corporation Formulations for coated microprojections containing non-volatile counterions
BRPI0412202A (pt) * 2003-07-02 2006-08-22 Alza Corp emplastro para imunização tendo um arranjo de microprojeções, e método
EP1658035A4 (en) 2003-08-25 2007-08-22 3M Innovative Properties Co ADMINISTRATION OF MODIFIERS OF IMMUNE RESPONSE
WO2005042702A2 (en) * 2003-10-23 2005-05-12 Alza Corporation Compositions of stabilized dna for coating microprojections
CA2543086A1 (en) 2003-10-24 2005-05-12 Alza Corporation Pretreatment method and system for enhancing transdermal drug delivery
KR20070010115A (ko) * 2003-11-13 2007-01-22 알자 코포레이션 경피전달용 조성물 및 장치
JP2007530680A (ja) 2004-04-01 2007-11-01 アルザ・コーポレーシヨン インフルエンザワクチンの経皮デリバリーのための装置および方法
WO2005102334A2 (en) * 2004-04-13 2005-11-03 Alza Corporation Apparatus and method for transdermal delivery of fentany-based agents
JP2007537783A (ja) * 2004-04-13 2007-12-27 アルザ コーポレイション 複数のワクチンを経皮送達するための装置及び方法
KR20070042573A (ko) * 2004-08-11 2007-04-23 알자 코포레이션 나트륨 이뇨 펩티드의 경피 전달 장치 및 그 방법
WO2006055844A2 (en) 2004-11-18 2006-05-26 3M Innovative Properties Company Method of contact coating a microneedle array
US8057842B2 (en) 2004-11-18 2011-11-15 3M Innovative Properties Company Method of contact coating a microneedle array
EP1827564B1 (en) * 2004-11-18 2015-07-29 3M Innovative Properties Company Masking method for coating a microneedle array
CN101160117A (zh) * 2005-02-16 2008-04-09 阿尔扎公司 依泊汀-基药物的透皮释放装置和方法
US20060253079A1 (en) * 2005-04-25 2006-11-09 Mcdonough Justin Stratum corneum piercing device
US20070270738A1 (en) * 2005-04-25 2007-11-22 Wu Jeffrey M Method of treating ACNE with stratum corneum piercing patch
US20080195035A1 (en) * 2005-06-24 2008-08-14 Frederickson Franklyn L Collapsible Patch and Method of Application
US20070078414A1 (en) * 2005-08-05 2007-04-05 Mcallister Devin V Methods and devices for delivering agents across biological barriers
CA2629193C (en) * 2005-11-18 2016-03-29 3M Innovative Properties Company Coatable compositions, coatings derived therefrom and microarrays having such coatings
EP2018835B1 (de) * 2007-07-09 2014-03-05 Augustinus Bader Wirkstoff abgebendes Pflaster
US8617487B2 (en) 2009-03-25 2013-12-31 Venture Lending & Leasing Vi, Inc. Saliva sample collection systems
WO2011010456A1 (ja) * 2009-07-24 2011-01-27 株式会社ネクスト２１ ＮＳＡＩＤｓ含有外用剤及び当該外用剤の製造方法
EP2818159A1 (de) * 2013-06-25 2014-12-31 LTS LOHMANN Therapie-Systeme AG Vorrichtung mit transdermalem therapeutischem System, Positionier- und Penetrationshilfe
US9987361B1 (en) * 2014-12-29 2018-06-05 Noven Pharmaceuticals, Inc. Compositions and method for sustained drug delivery by active transdermal technology
DE102017126501A1 (de) 2017-11-10 2019-05-16 Lts Lohmann Therapie-Systeme Ag Mikronadelsystem zur Applikation eines Hepatitis-Impfstoffes
US20190231925A1 (en) * 2018-01-31 2019-08-01 Changchun Ja Biotech. Co., Ltd. Heparin sodium supported hydrogel sustained-release paster

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE25637E (en) 1964-09-08 Means for vaccinating
US3964482A (en) 1971-05-17 1976-06-22 Alza Corporation Drug delivery device
BE795384A (fr) 1972-02-14 1973-08-13 Ici Ltd Pansements
EP0429842B1 (en) 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
US5279544A (en) 1990-12-13 1994-01-18 Sil Medics Ltd. Transdermal or interdermal drug delivery devices
GB9118028D0 (en) * 1991-08-21 1991-10-09 Secr Defence Brit Improved transdrmal formulations
IL109037A (en) * 1993-03-19 1999-01-26 Cellegy Pharma Inc Preparations for causing phase separation of lipid layers and preparation of the above preparations
US5458140A (en) 1993-11-15 1995-10-17 Non-Invasive Monitoring Company (Nimco) Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers
US5885211A (en) 1993-11-15 1999-03-23 Spectrix, Inc. Microporation of human skin for monitoring the concentration of an analyte
DE59505328D1 (de) * 1994-12-09 1999-04-15 Novartis Ag Transdermales system
AU5869796A (en) 1995-05-22 1996-12-11 Ned A. Godshall Micromechanical patch for enhancing the delivery of compound s through the skin
AU5740496A (en) * 1995-05-22 1996-12-11 General Hospital Corporation, The Micromechanical device and method for enhancing delivery of compounds through the skin
DE19525607A1 (de) * 1995-07-14 1997-01-16 Boehringer Ingelheim Kg Transcorneales Arzneimittelfreigabesystem
US5902603A (en) * 1995-09-14 1999-05-11 Cygnus, Inc. Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems, and associated methods of manufacture and use
DE19541260A1 (de) * 1995-11-06 1997-05-07 Lohmann Therapie Syst Lts Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut
US6230051B1 (en) 1996-06-18 2001-05-08 Alza Corporation Device for enhancing transdermal agent delivery or sampling
ATE241405T1 (de) 1996-07-03 2003-06-15 Altea Therapeutics Corp Mehrfache mechanische mikroperforierung von haut oder schleimhäuten
ATE231015T1 (de) 1996-09-17 2003-02-15 Deka Products Lp System zur medikamentenabgabe durch transport
CN1133472C (zh) 1996-12-20 2004-01-07 阿尔萨公司 增加经皮样剂流量的装置
DE19654391A1 (de) 1996-12-27 1998-07-02 Basf Ag Katalysator zur selektiven Herstellung von Propylen aus Propan
WO1998029134A2 (en) * 1996-12-31 1998-07-09 Altea Technologies, Inc. Microporation of tissue for delivery of bioactive agents
US6918901B1 (en) 1997-12-10 2005-07-19 Felix Theeuwes Device and method for enhancing transdermal agent flux
DE69831268T2 (de) * 1997-12-11 2006-03-09 Alza Corp., Palo Alto Vorrichtung zur erhöhung des transdermalen wirkstoffeflusses
PT1037687E (pt) 1997-12-11 2008-12-17 Alza Corp Dispositivo para melhoramento de fluxo transdérmico de agente
DE69806963T2 (de) * 1997-12-11 2002-11-21 Alza Corp., Mountain View Vorrichtung zur erhöhung des transdermalen wirkstoffeflusses
US6022316A (en) 1998-03-06 2000-02-08 Spectrx, Inc. Apparatus and method for electroporation of microporated tissue for enhancing flux rates for monitoring and delivery applications
EP1086214B1 (en) 1998-06-10 2009-11-25 Georgia Tech Research Corporation Microneedle devices and methods of their manufacture
AU771818B2 (en) * 1999-05-17 2004-04-01 Stephen T Flock Remote and local controlled delivery of pharmaceutical compounds using electromagnetic energy
WO2000074763A2 (en) * 1999-06-04 2000-12-14 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
ES2238333T3 (es) * 1999-12-10 2005-09-01 Alza Corporation Aparato de tratamiento dermico para la administracion prolongada de farmacos por via transdermica.
WO2001041863A1 (en) * 1999-12-10 2001-06-14 Alza Corporation Device and method for enhancing microprotrusion skin piercing
ATE367805T1 (de) * 2000-09-08 2007-08-15 Alza Corp Transdermale vorrichtung
ATE428466T1 (de) 2000-10-26 2009-05-15 Alza Corp Transdermales arzneistoffverabreichungssytem mit beschichteten mikrovorsprüngen
US20040115167A1 (en) * 2002-09-30 2004-06-17 Michel Cormier Drug delivery device and method having coated microprojections incorporating vasoconstrictors

Also Published As

Publication number Publication date
BR0113749A (pt) 2004-06-22
ZA200302700B (en) 2004-08-13
DK1335711T3 (da) 2007-11-26
RU2272618C2 (ru) 2006-03-27
PL365603A1 (en) 2005-01-10
CN1473037A (zh) 2004-02-04
ATE367805T1 (de) 2007-08-15
KR20030074595A (ko) 2003-09-19
DE60129585D1 (de) 2007-09-06
MXPA03002122A (es) 2004-09-10
CN100421653C (zh) 2008-10-01
ES2290166T3 (es) 2008-02-16
WO2002019985A3 (en) 2002-09-06
EE200300095A (et) 2005-02-15
EP1335711B1 (en) 2007-07-25
AU2001288774B2 (en) 2006-06-29
JP5507030B2 (ja) 2014-05-28
KR100764699B1 (ko) 2007-10-08
CA2422200A1 (en) 2002-03-14
WO2002019985A2 (en) 2002-03-14
US7438926B2 (en) 2008-10-21
JP2013256500A (ja) 2013-12-26
IL154811A0 (en) 2003-10-31
PT1335711E (pt) 2007-09-05
DE60129585T2 (de) 2008-04-17
AU8877401A (en) 2002-03-22
JP2004508319A (ja) 2004-03-18
NO20031071D0 (no) 2003-03-07
EP1335711A2 (en) 2003-08-20
MA25958A1 (fr) 2003-12-31
US20020102292A1 (en) 2002-08-01
CZ2003687A3 (cs) 2004-01-14
NZ524646A (en) 2004-10-29

Similar Documents

Publication Publication Date Title
NO20031071D0 (no) Fremgangsmåte for å inhibere nedgang i transdermal medikamentgjennomströmming ved inhibisjon ved lukking av reaksjonsveien
WO2003032914A3 (en) Methods for treating substance abuse with cholinesterase inhibitors
WO2005018677A3 (en) Use of combination of an epidermal growth factor receptor kinase inhibitor and cytotoxic agents for treatment and inhibition of cancer
WO2004006906A3 (en) Methods for the treatment of neoplasms
BRPI0006634B8 (pt) composição tópica compreendendo extrato de matricária no tratamento e prevenção de distúrbios inflamatórios
MX2009005201A (es) Derivados de estratrieno sustituidos como inhibidores de 17beta hsd.
PL1624878T3 (pl) Zastosowanie kompozycji zawierającej estrogenowy składnik w celu leczenia i zapobiegania bólowi mięśniowo-szkieletowemu
WO2002049630A3 (en) Method for preventing or treating pain by administering an endothelin antagonist
WO2005044194A3 (en) TREATMENT OR PREVENTION OF NEOPLASIA BY USE OF AN Hsp90 INHIBITOR
WO2001087343A3 (en) Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
WO2003092606A3 (en) Cholinesterase inhibitors to prevent injuries caused by chemicals
IL122960A0 (en) Pharmaceutical compositions for use in the treatment of colonic adenomas
WO2007143185A3 (en) Transdermal treatment of tendinopathy using glyceryl trinitrite
WO2002096351A3 (en) Ultrashort-acting opioids for transdermal application
WO2005037347A3 (en) Treatment of overuse tendinopathy using transdermal nitric oxide-generating agents
WO2004007676A3 (en) Combination therapy for the treatment of neoplasms
WO2006047392A3 (en) Nicotinic-opioid synergy for analgesia
DE60213116D1 (de) Verwendung von carbinolen zur behandlung von neuropathischer funktionsstörung
WO2007123511A3 (en) Dosing regimens for the treatment of cancer
WO2000023062A3 (en) Irrigation solution and method for inhibition of pain and inflammation
WO2006068796A3 (en) Inhibitors of akt activity
WO2007103190A3 (en) Transdermal treatment of tendinop athy using no donor
GEP201606538B (en) Preoperative treatment of post operative pain
WO2004028448A3 (en) Method of alleviating pain via inhibition of neurotransmitter synthesis
ATE372126T1 (de) Spüllösung und verfahren zur schmerzlinderung und entzündungshemmung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application